Vikas Ahuja

Vikas Ahuja, Chief Business Officer, is responsible for the development of partnerships with biopharma companies. Vikas brings 20+ years of experience in strategy and business development leadership roles in Life Sciences across Biopharma, Diagnostics and Genomics. He previously led strategic partnerships at Nucleai, an AI driven spatial biology startup, and was formerly Vice President, Business Development & Strategy at Ambry Genetics (now TempusAI). Prior to that he led the International business at Mallinckrodt Pharmaceuticals and previously held corporate and commercial strategy leadership roles at Quest Diagnostics. Vikas holds an MBA from the Wharton School at the University of Pennsylvania, and a Masters in Chemical Engineering from Imperial College, London.